BOTANIX PHARMACEUTICALS LTD — Director's Dealing 2019

Feb 10, 2019

Appendix 3Z Final Director’s Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Botanix Pharmaceuticals Limited ACN 70 009 109 755

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Mr Graham Griffiths
Date of last notice	1 May 2018
Date that director ceased to be director	6 February 2019 (Dec’d)

Part 1 – Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

• See chapter 19 for defined terms.

11/3/2002

Appendix 3Z Page 1

Appendix 3Z Final Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest
Note: Provide details of the circumstances giving rise to the
relevant interest
Graham John Griffiths and Mrs Jillian	3,700,000	Ordinary Shares
Griffiths <Griffiths Private S/F A/C>
Jillian Margaret Griffiths<Sunnycrest	4,053,990	Unlisted Options, exercisable at
Investment A/C>	$0.0675 expiring 1 December 2019 and vesting
	progressively over three years at each 30
	November,	subject to continued service to the
	Company.

Part 3 – Director’s interests in contracts

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder	N/A
(if issued securities)
No. and class of securities to	N/A
which interest relates

• See chapter 19 for defined terms.

Appendix 3Z Page 2

11/3/2002